Document:

Primus Therapeutics, Inc.: Exhibit 10.1 - Filed by newsfilecorp.com

Exhibit 10.1

EMPLOYMENT AGREEMENT 

This Agreement (this “Agreement”), is effective as of the Effective Date (as defined below) by and between PRIMUS THERAPEUTICS, INC., a Delaware corporation with offices at 4390 U.S. Route 1, Suite 200, Princeton, NJ 08540 (the
“Company”), and DENNIS M. O’DONNELL, with an address at 66 South Stone Hedge Drive, Basking Ridge, NJ 07920 (the “Executive” and, together with Primus, collectively the “Parties” and each a
“Party”). 

W I T N E S S E T H: 

WHEREAS, the Company desires to employ the Executive as its President and Chief Executive Officer, and the Executive is willing to accept such employment, upon the terms and subject to the conditions contained in this Agreement; 

NOW, THEREFORE, in consideration of the mutual covenants and agreements herein contained, the parties hereto hereby agree as follows: 

1.
 Employment. 

(a) Services. The Company shall
employ the Executive as its President and Chief
Executive Officer. The Executive shall report to the Board of Directors of the Company (the
“Board”) and shall perform such duties as are consistent with his position as President and Chief
Executive Officer, as the Board may from time to time define. The Executive shall perform such
duties faithfully, devote all of his working time, attention and energies to the business of the
Company and, while he remains employed by the Company, shall not undertake or engage in any 
other business activity that is in conflict with his duties and obligations to the Company or
otherwise adversely affects his ability to comply with his obligations under this Agreement.

(b) Acceptance. The Executive
hereby accepts such employment as of
the Effective Date, as defined in Section 2 below, and agrees to render the services
described herein.

2.  Term. The Executive’s employment under this Agreement (the “Term”) shall
commence on a date to be selected by the Executive, which date (the “Effective Date”) shall not
be later than thirty (30) days after the closing of a bridge financing or private placement in an
aggregate amount of not less than Five Hundred Thousand Dollars ($500,000), provided,
however, that such closing shall occur no later than July 30, 2010 (the “Financing Condition”),
and shall continue for a term of three (3) years (the “Initial Term”), unless sooner terminated
pursuant to Section 9 of this Agreement. Notwithstanding anything to the contrary contained
herein, Sections 6, 7, 10, and 11 of this Agreement shall survive the expiration or termination
hereof. Upon termination of the Initial Term, this Agreement shall automatically renew for
additional one (1) year terms (each, a “Renewal Term”); provided, however, that (a) if, at least
three (3) months prior to the end of the Initial Term or any Renewal Term, as the case may be,
the Company gives written notice to the Executive that the Company elects that this Agreement
not be renewed, then this Agreement shall end and expire as of the end of the Initial Term or
such Renewal Term, as the case may be, or (b) if, at least three (3) months prior to the end of the
Initial Term or any Renewal Term, as the case may be, the Executive gives written notice to the
Company that the Executive elects that this Agreement not be renewed, then this Agreement shall end and expire as of the end of the Initial Term or such Renewal Term, as the case may be.

3.   Best Efforts; Place of Performance.

(a) The Executive shall devote substantially all of his business time,
attention and energies to the business and affairs of the Company and shall use his best efforts to advance the best interests of the Company. The Executive shall not during the Term undertake or engage in any other business activity, whether or not
such business activity is pursued for gain, profit or other pecuniary advantage, if and to the extent such other business activity interferes, or could reasonably be expected to interfere, with the performance by the Executive of his duties
hereunder or the Executive’s availability to perform such duties or that
could adversely affect, or negatively reflect upon, the Company, except as set forth above in Section 1(a). 

(b) The duties to be performed by the Executive hereunder shall be performed primarily at the office of the Company that shall be established in or around Bridgewater, New Jersey, or such other place as the Board may reasonably designate. The
Executive shall, from time to time undertake such travel as may be reasonably necessary to promote and sustain the business interests of the Company. 

4.   Directorship. The Company shall use its best efforts to cause the Executive to be elected as a member of its Board
of Directors throughout the Term and shall include the Executive in the management slate for election as a director at every Annual
General Meeting of stockholders convened during the Term at which the Executive’s term as a director would otherwise expire. The Executive agrees to accept election as a director and to serve during the Term as a director of the Company without
any additional compensation, subject to the Company’s obligation to reimburse the Executive for all out-of-pocket costs and expenses reasonably incurred by the Executive in fulfilling his responsibilities as a director, in accordance with such
guidelines or policies as the Board may from time to time adopt. 

5.   Compensation. As full compensation for the performance by the Executive of his duties under this Agreement, the Company shall pay the Executive as follows: 

(a) Base Salary. The Company shall pay the Executive an annualized salary (the “Base Salary”) of Three Hundred Thousand Dollars ($300,000). Payment shall be made in accordance with the Company’s normal payroll
practices. The Executive’s Base Salary shall be reviewed no less than annually by the Board.

(b) Bonus. Provided that the Company is operating profitably, the Board may, in its sole discretion, grand the Executive an annual bonus of up to one hundred percent (100%) of the Base Salary (the “Bonus”), based on the
Board’s evaluation of the Executive’s attainment of individual and corporate goals and in light of the Company’s overall performance. 

(c) Withholding. The Company shall withhold all applicable federal, state and local taxes and social security and such other amounts as may be required by law from all amounts payable to the Executive under this Section 5. 

- 2 -

 (d) Management Incentive Options. In order to properly attract, maintain and incentivize highly qualified senior managers and key talent, the Company shall set aside a pool of
 equity securities, commensurate with industry standards, for
distribution to such employees, including the Executive, as the Board, upon recommendation of its Compensation Committee, may determine. 

(e) Expenses. The Company shall reimburse the Executive for all normal, usual and necessary expenses incurred by the Executive in furtherance of the business and affairs of the Company, including reasonable travel and entertainment, upon
timely receipt by the Company of appropriate vouchers or other proof of the Executive’s expenditures and otherwise in accordance with any expense reimbursement policy as may from time to time be adopted by the Company. 

(f) Other Benefits. The Executive shall be entitled to all rights and benefits for which he
may be eligible under any corporate benefit or other plans (including, without limitation, dental, medical, medical reimbursement and hospital
plans, pension plans, employee stock purchase plans, profit sharing plans, bonus plans, prescription drug reimbursement plans, short and long term disability plans, life insurance and other so-called “fringe” benefits) as the Company may
make available to its senior executives from time to time.

(g) Vacation. The Executive shall be entitled to a vacation of twenty (20) days per annum, not more than ten (10) of which shall be taken in succession, in addition to public holidays observed by the Company. Commencing with the calendar year
ending December 31, 2011, the Executive shall forfeit any annual vacation days not utilized with fifteen (15) months following the start of such calendar year. 

(h) Expense Reimbursement and Benefits. Notwithstanding anything in this Agreement to the contrary, any expense reimbursement or benefit provided pursuant to Section 5(e), Section 5(f) or Section 10 shall be subject to the following: (i) the
amount of any such expense reimbursement or benefit provided during the Executive’s taxable year shall not affect any expenses eligible for reimbursement or benefit to be provided in any other taxable year; (ii) the reimbursement of any
eligible expense shall be made no later than the last day of the Executive’s taxable year that immediately follows the taxable year in which the expense was incurred; and (iii) the right to any such expense reimbursement or benefit shall not be
subject to liquidation or exchange for another benefit. 

6.   Confidential Information and Inventions.

(a) The Executive recognizes and acknowledges that in the course of his duties he is likely to receive confidential or proprietary information of the Company, its affiliates or third parties with whom the Company or any such affiliates has an
obligation of confidentiality. Accordingly, during and after the Term, the Executive agrees to keep confidential and not disclose or make accessible to any other person or use for any other purpose other than in connection with the fulfillment of
his duties under this Agreement, any Confidential Information owned by, or received by or on behalf of the Company or any of its
affiliates. “Confidential Information” means all technical, financial and business information of any kind whatsoever of or relating to the Company (whether written, oral, in electronic format, whether gathered by inspection or
observation and whether disclosed prior to or after the date of this Agreement) including without limitation the following: business plans and projections; financial statements and projections or forecasts of financial results; product
specifications; production and development processes, techniques, formulae, know-how and operating instructions; training manuals; computer programs; raw material, selling and logistics costs; production schedules; customer lists, purchasing history
and other customer-related records; names and addresses of suppliers and vendors; tax information; mailing lists; product sales records; marketing data and plans and results of market surveys; personnel lists, data and salary information; contracts;
correspondence (including e-mail communications); and any copies, summaries or annotation of any of the foregoing; provided, however, that the term “Confidential Information” shall not include any information (i) that the Executive
can document was lawfully in its possession prior to any disclosure thereof by the Company; or (ii) is obtained on a non-confidential basis from a source other than the Company, but only if such source has a lawful right to disclose such
Confidential Material; or (iii) is or becomes in the public domain. 

- 3 -

The Executive agrees to return immediately to the Company all Confidential Information in his possession  upon request and in any event immediately upon termination of employment. 

(b) Except with prior written authorization by the Company, the Executive agrees for a period of five (5) years from the termination of his employment with the Company not to disclose or publish: 

	
 	
 	
 	
(i) 		
any of the Confidential Information; or

	
	 	 	 	 	 
	
 	
 	
 	
(ii) 		
any confidential, scientific, technical or business information
of any other party to whom the Company or any of its affiliates owes an obligation of confidence. 

	

(c) The Executive agrees that all inventions, discoveries, improvements and patentable or copyrightable works initiated, conceived or made by him, either alone or in conjunction with others, during the Term (“Inventions”) shall be
the sole property of the Company to the maximum extent permitted by applicable law and, to the extent permitted by law, shall be “works made for hire” as that term is defined in the United States Copyright Act (17 U.S.C.A., Section 101).
The Company shall be the sole owner of all patents, copyrights, trade secret rights, and other intellectual property or other rights in connection therewith. The Executive hereby assigns to the Company all right, title and interest he may have or
acquire in all such Inventions. The Executive further agrees to assist the Company in every proper way (but at the Company’s expense) to obtain and from time to time enforce patents, copyrights or other rights on such Inventions in any and all
countries, and to that end the Executive shall execute all documents necessary: 

 (i) to apply for, obtain and vest in the name of the Company alone (unless the Company otherwise directs) letters patent, copyrights or other analogous
protection in any country throughout the world and when so obtained or vested to renew and restore the same; and 

 - 4 -

(ii) to defend any opposition proceedings in respect of such applications and any opposition proceedings or petitions or applications for revocation of such letters patent, copyright or other analogous protection. 

(d) The Executive acknowledges that while performing his duties hereunder, the Executive may locate, identify and/or evaluate patented or patentable inventions having commercial potential in fields that may be of potential interest to the Company or
one of its affiliates (the “Third Party Inventions”). The Executive understands, acknowledges and agrees that all rights to, interests in or opportunities regarding, all Third-Party Inventions identified by the Company, any of its
affiliates or either of the foregoing persons’ officers, directors, employees (including the Executive), agents or consultants during the Term shall be and remain the sole and exclusive property of the Company or such affiliate and the
Executive shall have no rights whatsoever to such Third-Party Inventions and will not pursue for himself or for others any transaction relating to the Third-Party Inventions which is not on behalf of the Company unless the Company has expressly
abandoned its interest in such Third Party Inventions in writing. 

(e) The Executive agrees that he will promptly disclose to the Company all Inventions initiated, made or conceived or reduced to practice, either alone or jointly with others, during the Term. 

(f) The provisions of this Section 6 shall survive any termination of this
Agreement .

7.    Non-Competition, Non-Solicitation and Non-Disparagement.

(a) The Executive understands and recognizes that his services to the
Company are special and unique and that in the course of performing such services the Executive will have access to and knowledge of Confidential
Information. The Executive agrees that, during the Term and during such period of time after the Term
that the Executive continues to receive his salary and benefits without interruption from the Company during the Termination Benefits Period (as defined hereinafter), other than in the event that the Executive is terminated for Cause, in which case
he will remain subject to this provision even in the absence of receiving any further salary or benefits, he shall not in any manner, directly or indirectly, on behalf of himself or any person, firm, partnership, joint venture, corporation or other
business entity (“Person”), enter into or engage in any business which is engaged in any business directly competitive with the business of the Company, either as an individual for his own account, or as a partner, joint venturer,
owner, executive, employee, independent contractor, principal, agent, consultant, salesperson, officer, director or shareholder of a Person in a business competitive with the Company within the geographic area of in which the Company does business.
The Executive acknowledges that, due to the nature of the Company’s business, the loss of any of its clients or the improper use of its Confidential Information could create significant instability and cause substantial damage to the Company
and therefore the Company has a strong legitimate
business interest in protecting the continuity of its business interests and the restriction herein agreed to by the Executive narrowly and fairly serves such an important and critical business interest of the Company. For purposes of this
Agreement, the Company shall be deemed to be actively engaged on the date hereof in the development, marketing and sale of “over-the-counter”, homeopathic and dietary supplement products. Notwithstanding the foregoing, nothing contained in
this Section 7(a) shall be deemed to prohibit the Executive from acquiring or holding, solely for investment, publicly traded securities of any corporation, some or all of the activities of which are competitive with the business of the Company so
long as such securities do not, in the aggregate, constitute more than four percent (4%) of any class or series of outstanding securities of such corporation. 

- 5 -

(b) The Executive hereby acknowledges and agrees that the covenant against competition provided for pursuant to Section 7(a) is reasonable with respect to duration, geographic area and scope. If, at the time of enforcement of this Section 7, a court
holds that the restrictions stated herein are unreasonable under the circumstances then existing, the parties hereto agree that the maximum duration, scope or geographic area legally permissible under such circumstances will be substituted for the
duration, scope or area state herein. 

(c) During the Term and the Termination Benefits Period (as defined hereinafter), the Executive shall not, directly or indirectly, without the prior written consent of the Company: 

(i) solicit or induce any employee of the Company or any of its affiliates to leave the employ of the Company or any such affiliate (as the term “affiliate” is defined in Paragraph 12(o)); or hire for any purpose any employee of the
Company or any affiliate; or hire any former employee who has left the employment of the Company or any affiliate of the Company within twelve (12) months of the termination of such employee’s employment with the Company or any such affiliate;
or hire any former employee of the Company in violation of such employee’s non-competition agreement with the Company or any such affiliate; or 

(ii) solicit or accept the business of any agent, client or customer of the Company or any of its affiliates with respect to products, services or investments similar to those provided or supplied by the Company or any of its affiliates; or 

(iii) solicit or accept employment or be retained by any Person who, at any time during the Term, was an agent, client or customer of the Company or any of its affiliates where his position will be related to the business of the Company or any such
affiliate. 

(d) The Company and the Executive each agree that both during the Term and for a period of five (5) years thereafter, neither party shall directly or indirectly make any disparaging statement, whether or not true, with respect to the name or
reputation of the other party or any of its affiliates, including but not limited to, any officer, director, employee or shareholder of the Company or any of its affiliates (as defined above). Notwithstanding this Section, nothing contained herein
shall limit or impair the ability of the Executive to provide truthful testimony in response to any validly issued subpoena. 

- 6 -

(e) In the event that the Executive breaches any provisions of Section 6 or this Section 7 or there is a threatened breach, then, in addition to any other rights which the Company may have, the Company shall (i) be entitled, without the posting of a
bond or other security, to seek injunctive relief to enforce the restrictions contained in such Sections and (ii) to the extent permitted by law, have the right to require the Executive to account to the Company all compensation, profits, monies,
accruals, increments and other benefits (collectively “Benefits”) derived or received by the Executive as a result of any transaction constituting a breach of any of the provisions of Sections 6 or 7 and the Executive hereby agrees
to account for and pay over such Benefits to the Company. The Company and the Executive agree that any such action for injunctive relief shall be heard in any of the courts set forth in Section 12(c) below, and each of the parties hereto agrees to
accept service of process by registered or certified mail and to otherwise consent to the jurisdiction of such courts. 

(f) Each of the rights and remedies enumerated in Section 7(e) shall be independent of the others and shall be in addition to and not in lieu of any other rights and remedies available to the Company at law or in equity. If any of the covenants
contained in this Section 7, or any part of any of them, is hereafter construed or adjudicated to be invalid or unenforceable, the same shall not affect the remainder of the covenant or covenants or rights or remedies which shall be given full
effect without regard to the invalid portions. If any of the covenants contained in this Section 7 is held to be invalid or unenforceable because of the duration of such provision or the area covered thereby, the parties agree that the court or
arbitrator making such determination shall have the power to reduce the duration and/or area of such provision and in its reduced form such provision shall then be enforceable. No such holding of invalidity or unenforceability in one jurisdiction
shall bar or in any way affect the Company’s right to the relief provided in this Section 7 or otherwise in the courts of any other state or jurisdiction within the geographical scope of such covenants as to breaches of such covenants in such
other respective states or jurisdictions, such covenants being, for this purpose, severable into diverse and independent covenants. 

(g) In the event that an actual proceeding is brought in equity to enforce the provisions of Section 6 or this Section 7, the Executive shall not urge as a defense that there is an adequate remedy at law nor shall the Company be prevented from
seeking any other remedies which may be available. The Executive agrees that he shall not raise in any proceeding brought to enforce the provisions of Section 6 or this Section 7 that the covenants contained in such Sections limit his ability to
earn a living during the Termination Benefit Period (as defined hereinafter). 

(h) The provisions of this Section 7 shall survive any termination of this Agreement. 

8.    Representations and Warranties. The Executive hereby represents and warrants to the Company as follows: 

(a) Neither the execution or delivery of this Agreement nor the performance by the Executive of his duties and other obligations hereunder violate or will violate any statute, law, determination or award, or conflict with or constitute a default or
breach of any
covenant or obligation under (whether immediately, upon the giving of notice or lapse of time or both) any prior employment agreement, contract, or other instrument to which the Executive is a party or by which he is bound. 

- 7 -

(b) The Executive has the full right, power and legal capacity to enter and deliver this Agreement and to perform his duties and other obligations hereunder. This Agreement constitutes the legal, valid and binding obligation of the Executive
enforceable against him in accordance with its terms. No approvals or consents of any persons or entities are required for the Executive to execute and deliver this Agreement or perform his duties and other obligations hereunder. 

9.    Termination. The Executive’s employment hereunder shall be terminated upon the Executive’s death and may be terminated as follows: 

(a) The Executive’s employment hereunder may be terminated by the Board for Cause. Any of the following actions by the Executive shall constitute “Cause”: 

(i) The willful failure, disregard or refusal by the Executive to perform his material duties or obligations under this Agreement, which shall require affirmative or intentional improper actions or omissions by the Executive and not simply actions
that result in the performance of the Company overall or in certain respects that falls below levels expected by, or acceptable to, the Board; 

(ii) Any willful, intentional or grossly negligent act by the Executive having the effect of materially injuring (whether financial or otherwise and as determined in good-faith by a majority of the members of the Board) the business or reputation of
the Company or any of its affiliates, including but not limited to, any officer, director, executive or shareholder of the Company or any of its affiliates; 

(iii) Willful misconduct by the Executive in respect of the material duties or obligations of the Executive under this Agreement, including, without limitation, willful insubordination with respect to lawful and reasonable directions received by the
Executive from the Board; 

(iv) The Executive’s indictment of any felony involving moral turpitude (including entry of a plea of nolo contendere); 

(v) The determination by the Company, after a reasonable and good-faith investigation by the Company following a written allegation by another employee of the Company, (which investigation, among other actions, shall include the Executive’s
opportunity to respond fully to any such allegation) that the Executive engaged in some form of harassment prohibited by law (including, without limitation, age, sex or race discrimination), unless the Executive’s actions were specifically
directed by the Board; 

(vi) Any material misappropriation or embezzlement of the property of the Company or its affiliates (whether or not a misdemeanor or felony); 

 - 8 -

(vii) Breach by the Executive of any of the provisions of Sections 6, 7 or 8 of this Agreement, which is not cured by the Executive within thirty (30) days after notice thereof is given to the Executive by the Company; and 

(viii) Breach by the Executive of any material provision of this Agreement other than those contained in Sections 6, 7 or 8 which, to the extent it is reasonably subject to notice and cure, is not cured by the Executive within thirty (30) days after
notice thereof is given to the Executive by the Company. 

(b) The Executive’s employment hereunder may be terminated by the Board due to the Executive’s Disability. For purposes of this Agreement, a termination for “Disability” shall occur (i) when the Board has provided a
written termination notice to the Executive supported by a written statement from a reputable independent physician to the effect that the Executive shall have become so physically or mentally incapacitated as to be unable to resume, within the
ensuing six (6) months, his employment under this Agreement by reason of physical or mental illness or injury or (ii) upon rendering of a written termination notice by the Board after the Executive has been unable to substantially perform his duties
hereunder for 60 or more consecutive days, or more than 120 days in any consecutive twelve month period, by reason of any physical or mental illness or injury. For purposes of this Section 9(b), the Executive agrees to make himself available and to
cooperate in a reasonable examination by a reputable independent physician retained by the Company. 

(c) The Executive’s employment hereunder may be terminated by the Board (or its successor) upon the occurrence of a Change of Control. For purposes of this Agreement, “Change of Control” means (i) the acquisition, directly or
indirectly, following the date hereof by any person (as such term is defined in Section 13(d) and 14(d)(2) of the Securities Exchange Act of 1934, as amended), in one transaction or a series of related transactions, of securities of the Company
representing in excess of fifty percent (50%) or more of the combined voting power of the Company’s then outstanding securities if such person or his or its affiliate(s) do not own in excess of 50% of such voting power on the date of this
Agreement, or (ii) the future disposition by the Company (whether direct or indirect, by sale of assets or stock, merger, consolidation or otherwise) of all or substantially all of its business and/or assets in one transaction or series of related
transactions (other than a merger effected exclusively for the purpose of changing the domicile of the Company). 

(d) The Executive’s employment hereunder may be terminated by the Executive for Good Reason. 

(i) For purposes of this Agreement, “Good Reason” shall mean (any of which shall constitute a “Good Reason Condition”): 

(A) any material breach of this Agreement by the Company; 

-9-

(B) without the Executive’s express written consent, a material reduction by the Company of the Executive’s duties, responsibilities, or authority as President and Chief Executive Officer of the Company which causes his position with the
Company to become of less responsibility or authority than his position as of immediately following the Commencement Date; or 

(C) a relocation of the Company’s principal place of business of the Executive more than thirty (30) miles from Executive’s residence in Basking Ridge, New Jersey without the Executive’s written consent. 

(ii) The Executive may terminate his employment for Good Reason for any of the reasons stated above only if (A) the Executive has provided the Company with written notice of the asserted Good Reason Condition within ninety (90) days after its
initial existence; (B) the Company fails to cure the condition within thirty (30) days after receiving such written notice; and (C) the Executive terminates this employment within one hundred and eighty (180) days following the initial existence of
the Good Reason condition. 

(e) The Executive’s employment may be terminated by the Company or by the Executive with or without Cause or Good Reason. 

10.    Compensation upon Termination.

(a) If the Executive’s employment is terminated as a result of his death
or Disability, the Company shall pay to the Executive or to the Executive’s estate, as applicable, (i) his Base Salary through the date of his termination, benefits (if disabled), and any expense reimbursement amounts owed the Executive, and
(ii) any accrued but unpaid bonuses earned by the Executive prior to the date of the Executive’s death or Disability. Subject to Section 10(f), any such payments of Base Salary and/or bonuses shall be made to the Executive or to the
Executive’s estate, as applicable, within ninety (90) days after his death or Disability. Any stock options granted under any stock incentive plan that are scheduled to vest on the next succeeding anniversary of the Commencement Date shall be
accelerated and deemed to have vested as of the termination date, and all others shall be terminated as of such date. Stock options that have vested as of the Executive’s termination shall remain exercisable for ninety (90) days following such
termination. 

(b) If the Executive’s employment is terminated by the Board for Cause, then the Company shall pay to the Executive his Base Salary through the date of his termination and any expense reimbursement amounts owed the Executive. The Executive
shall have no further entitlement hereunder to any other compensation or benefits from the Company except to the extent otherwise provided by law. Any stock options that have not vested as of the date of termination shall be terminated as of such
date. Stock options that have vested as of the Executive’s termination shall remain exercisable for ninety (90) days following such termination.

(c) If the Executive’s employment is terminated by the Company other than as a result of the Executive’s death or Disability and other than for reasons specified in Section 10(b) or 10(d), or if the Executive terminates his employment for
Good Reason, then the
Company shall (i) continue to pay to the Executive his Base Salary and benefits for a period of eighteen (18) months following the termination of the Term (the “Section 10(c) Termination Benefits Period”); (ii) pay any accrued but
unpaid bonuses earned by the Executive; (iii) pay any accrued and unused vacation days earned by the Executive; and (iv) pay any expense reimbursement amounts owed the Executive. Subject to Section 10(f), (i) any such payments of Base Salary and
unused vacation days shall be made to the Executive on the Company’s normal payroll dates during the Section 10(c) Termination Benefits Period, and (ii) any bonus payments shall be made to the Executive by the date that is no later than ninety
(90) days following the Executive’s termination. In addition, in the event of any such termination, all employee stock options that are scheduled to vest during the twelve (12) month period following such termination shall be accelerated and
deemed to have vested as of the termination date. All employee stock options that have vested (or been deemed pursuant to the immediately preceding sentence to have vested) as of the date of the Executive’s termination shall remain exercisable
for a period of ninety (90) days. 

- 10 -

(d) If the Executive’s employment is terminated by the Company (or its successor) upon the occurrence of a Change of Control, and on the date of termination pursuant to this Section 10(d), then the Company (or its successor, as applicable)
shall continue to pay to the Executive his Base Salary and benefits for a period of six (6) months following the termination of the Term (the “Section 10(d) Termination Benefits Period”, referred to along with the Section 10(c)
Termination Benefits Period as the “Termination Benefits Period”). In addition, in the event of any such termination, the Company shall pay the Executive any accrued but unpaid bonus; and (ii) any accrued and unused vacation days;
and (iii) any expense reimbursement amounts owed the Executive. Subject to Section 10(f), (i) any such payments of Base Salary and unused vacation days shall be made to the Executive on the Company’s normal payroll dates during the Section
10(d) Termination Benefits Period, and (ii) any such payments of any accrued but unpaid bonus shall be made to the Executive by the date that is no later than ninety (90) days following the Executive’s termination. Vesting of all Stock Benefits
shall be accelerated in full and deemed to have fully vested as of the termination date. Stock Benefits that have vested as of, or that vest in consequence of, the Executive’s termination shall remain exercisable for ninety (90) days following
such termination. Any stock options granted to Executive under any stock incentive plan that are unvested shall be accelerated and deemed to have vested as of the date of any Change in Control and shall remain exercisable for ninety (90) days
following such Change in Control. 

(e) Notwithstanding anything to the contrary in this Agreement, the following shall apply to any benefits provided under Section 10 that constitute “deferred compensation” within the meaning of Section 409A of the Internal Revenue Code of
1986, as amended (the “Code”) and the regulations and other guidance thereunder and any state law of similar effect (collectively “Section 409A”): 

(i) Any payment of such benefits shall not commence in connection with the Executive’s termination of employment unless and until the Executive has also incurred a “separation from service,” (as defined in Treasury Regulations Section
1.409A -1(h)) (“Separation from Service”) or such termination of employment is due to the Executive’s death, unless the Company reasonably determines that such amounts may be provided to the
Executive without causing the Executive to incur the adverse personal tax consequences under Section 409A. 

- 11 -

(ii) It is intended that (A) each installment of any such benefits be regarded as a separate “payment” for purposes of Treasury Regulations Section 1.409A -2(b)(2)(i), (B) all payments of any such benefits satisfy, to the greatest extent
possible, the exemptions from the application of Section 409A provided under Treasury Regulations Sections 1.409A -1(b)(4) and 1.409A -1(b)(9)(iii), and (C) any such benefits consisting of premiums payable under the Consolidated Omnibus Budget
Reconciliation Act of 1985 (“COBRA”) also satisfy, to the greatest extent possible, the exemption from the application of Section 409A provided under Treasury Regulations Section 1.409A -1(b)(9)(v). However, if the Company
determines that any such benefits constitute “deferred compensation” under Section 409A and the Executive is a “specified employee” of the Company, as such term is defined in Section 409A(a)(2)(B)(i), then, solely to the extent
necessary to avoid the imposition of the adverse personal tax consequences under Section 409A, (i) the timing of such benefit payments shall be delayed until the earlier of (a) the date that is six (6) months and one (1) day after the
Executive’s Separation from Service and (b) the date of the Executive’s death (such applicable date, the “Delayed Initial Payment Date”), and (ii) the Company shall (a) pay the Executive a lump sum amount equal to the sum
of the benefit payments that the Executive would otherwise have received through the Delayed Initial Payment Date if the commencement of the payment of the benefits had not been delayed pursuant to this paragraph and (b) commence paying the balance,
if any, of the benefits in accordance with the applicable payment schedule. 

(g) This Section 10 sets forth the only obligations of the Company with respect to the termination of the Executive’s employment with the Company, and the Executive acknowledges that, upon the termination of his employment, he shall not be
entitled to any payments or benefits which are not explicitly provided in Section 10. 

(h) Upon termination of the Executive’s employment hereunder for any reason, the Executive shall be deemed to have resigned as director of the Company, effective as of the date of such termination. 

(i) The obligations of the Company that arise under this Section 10 shall survive the expiration or earlier termination of this Agreement. 

11.    Indemnification. The Company shall defend and indemnify the Executive in his capacity as President and Chief Executive Officer of the Company to the fullest extent permitted under to the Delaware General Corporate Law (the
“DGCL”) and in accordance with the Company’s Bylaws and Certificate of Insurance. The Company shall also establish a policy for indemnifying its officers and directors, including but not limited to the Executive, for all
actions permitted under the DGCL taken in good faith pursuit of their duties for the Company, including but not limited to the obtaining of an appropriate level of Directors and Officers Liability coverage and including such provisions in the
Company’s by-laws or certificate of incorporation, as applicable and customary. The rights to indemnification shall survive any termination of this Agreement. 

- 12 -

12.  Miscellaneous.

(a) This Agreement shall be governed by, and construed and interpreted
in accordance with, the laws of the State of Delaware, without giving effect to its principles of conflicts of laws. 

(b) Executive and Company agree that any and all controversies or claims (whether contract, tort or statutory) between Executive and the Company arising out of Executive’s employment, the termination of that employment, and any agreements
previously or hereafter entered into by Executive and Company in connection with such employment relationship, that could have been filed in a court of law (or an administrative agency) shall be settled by final and binding arbitration. The claims
covered by this Agreement include, but are not limited to, claims for wrongful termination, wages or other compensation due, breach of contract, tort, discrimination or harassment (including race, sex, religion, national origin, age, marital status,
medical condition or disability), violation of any public policies, and claims for violation of federal, state or other governmental law, statute, regulation or ordinance. 

(c) The arbitration shall be conducted in accordance with the National Rules for the Resolution of Employment Disputes of the American Arbitration Association then in effect before a single arbitrator mutually selected by the Executive and the
Company. For the purpose of any judicial proceeding to enforce such award or incidental to such arbitration or to compel arbitration and for purposes of Sections 6 and 7 hereof, the parties hereby submit to the non-exclusive jurisdiction of the
courts of the state of New Jersey, or the United States District Court for the District of New Jersey. Service of process in such arbitration or court proceedings shall be satisfactorily made upon a Party if sent by registered mail addressed to it
at the address referred to below in paragraph (m) of this Section 12. 

(d) The Arbitrator shall be empowered to award any party any remedy at law or in equity that the prevailing party would otherwise have been entitled to had the matter been litigated or pursued in a civil court or administrative forum including, but
not limited to, general, special, and punitive damages, and injunctive relief. However, the Arbitrator’s authority to award any remedy is subject to whatever limitations, if any, exist in the applicable law on such remedies. Any award pursuant
to arbitration hereunder shall be included in a written decision that will state the legal and factual basis for the award and shall set forth the basis for calculating any damages award. The arbitrator’s award, order or judgment shall be
deemed final and binding upon the parties, except to the extent that it is shown to be violative of the law. 

(e) A demand for arbitration must be submitted within the limitations period that would be applicable in court. If either party does not submit and serve a written demand for arbitration within the applicable statute of limitations, such failure
shall constitute an absolute bar to the institution of any proceedings in any forum, and shall constitute a waiver of any rights regarding that claim. 

(f) Neither Party nor the arbitrator may disclose the existence, content or results of any arbitrations under this Agreement without the prior written consent of all parties hereto. 

- 13 -

(g) Pending such resolution of any claim, the Executive shall be entitled to continue to receive all payments and benefits due under this Agreement or otherwise, unless the arbitration panel determines otherwise. Judgment on the arbitration award
may be entered by any court of competent jurisdiction. 

(h) Nothing in this Agreement shall prevent the parties from agreeing voluntarily after a claim or controversy has arisen to submit such claim or controversy to mediation or other informal settlement process. However, if the dispute is not resolved
through mediation or such other process, it shall be submitted to binding arbitration pursuant to this Agreement. 

(i) This Agreement shall be binding upon and inure to the benefit of the parties hereto, and their respective heirs, legal representatives, successors and assigns. 

(j) This Agreement, and the Executive’s rights and obligations hereunder, may not be assigned by the Executive. The Company may assign its rights, together with its obligations, hereunder in connection with any sale, transfer or other
disposition of all or substantially all of its business or assets. 

(k) This Agreement cannot be amended orally, or by any course of conduct or dealing, but only by a written agreement signed by the parties hereto. 

(l) The failure of either party to insist upon the strict performance of any of the terms, conditions and provisions of this Agreement shall not be construed as a waiver or relinquishment of future compliance therewith, and such terms, conditions
and provisions shall remain in full force and effect. No waiver of any term or condition of this Agreement on the part of either party shall be effective for any purpose whatsoever unless such waiver is in writing and signed by such party. 

 (m) All notices, requests, consents and other communications, required or permitted to be given hereunder, shall be in writing and shall be delivered personally or by an overnight courier service or sent by registered or certified mail, postage
prepaid, return receipt requested, to the parties at the addresses set forth on the first page of this Agreement, and shall be deemed given when so delivered personally or by overnight courier or when actually received if sent by registered or
certified mail. Each party may designate another address, for receipt of notices hereunder by giving notice to the other party in accordance with this paragraph (m) of this Section 12. 

(n) This Agreement sets forth the entire agreement and understanding of the parties relating to the subject matter hereof, and supersedes all prior agreements, arrangements and understandings, written or oral, relating to the subject matter hereof.
No representation, promise or inducement has been made by either party that is not embodied in this Agreement, and neither party shall be bound by or liable for any alleged representation, promise or inducement not so set forth. 

- 14 -

(o) As used in this Agreement, “affiliate” of a specified Person shall mean and include any Person controlling, controlled by or under common control with the specified Person. 

(p) The section headings contained herein are for reference purposes only and shall not in any way affect the meaning or interpretation of this Agreement. 

(q) This Agreement may be executed in any number of counterparts, each of which shall constitute an original, but all of which together shall constitute one and the same instrument. 

(r) As used in this Agreement, the masculine, feminine or neuter gender, and the singular or plural, shall be deemed to include the others whenever and wherever the context so requires. Additionally, unless the context requires otherwise,
“or” is not exclusive. 

IN WITNESS WHEREOF, the parties hereto have executed this Agreement, which shall be deemed effective as of the Commencement Date set forth herein. 

Primus Therapeutics, Inc. 

By:   /s/ Joseph A. Falsetti 

         Joseph A. Falsetti 

 

Dennis M. O’Donnell 

By:   /s/ Dennis M. O’Donnell 

         Dennis M. O’Donnell 

 - 15 -Primus Therapeutics, Inc.: Exhibit 10.2- Filed by newsfilecorp.com

Exhibit 10.2

EMPLOYMENT AGREEMENT 

THIS EMPLOYMENT AGREEMENT (the “Agreement”), is entered
into as of the 5th day of November, 2010 (the “Effective
Date”) by and between PRIMUS THERAPEUTICS, INC., a Delaware corporation with
offices at 23 Orchard Road, Suite 105, Skillman, NJ 08588 (the
“Company”), and MARK I. MASSAD, with an address at 8 Dorchester Court,
Princeton, NJ 08542 (the “Executive” and, together with the Company,
collectively the “Parties” and each a “Party”). 

W I T N E S S E T H: 

WHEREAS the Company desires to employ the Executive as its
Treasurer and Chief Financial Officer, and the Executive is willing to accept
such employment, upon the terms and subject to the conditions contained in this
Agreement; 

NOW, THEREFORE, in consideration of the mutual covenants and
agreements herein contained, the parties hereto hereby agree as follows: 

1. Employment; Duties; Term 

a. Employment. The Company hereby employs the Executive,
and the Executive hereby agrees to serve, as the Company’s Treasurer and Chief
Financial Officer, on the terms and conditions hereinafter set forth. The
Executive shall report to the President & Chief Executive Officer of the
Company.

b. Term. The Executive’s employment under this Agreement
(the “Term”) shall commence as of the Effective Date and shall continue
until terminated as provided in this Agreement.

c. Duties of Employment. The Executive shall perform
such duties as are generally consistent with his position as Treasurer and Chief
Financial Officer, and as the Company may from time to time reasonably require.
Without limiting the generality of the foregoing, The Executive shall have
responsibility for supervising the Company’s financial, accounting and tax
functions, the development and maintenance of a system of internal controls on
financial reporting, and liaison (together with the Chairman of the Company’s
Audit Committee) with the Company’s external accountants. The Executive shall
also serve as the Company’s Principal Accounting Officer.

d. Best Efforts. The Executive shall devote
substantially all of his business time, attention and energies to the business
and affairs of the Company and shall use his best efforts to advance the best
interests of the Company. The Executive shall not during the Term undertake or
engage in any other business activity, whether or not such business activity is
pursued for gain, profit or other pecuniary advantage, if and to the extent such
other business activity interferes, or could reasonably be expected to
interfere, with the performance by the Executive of his duties hereunder or the
Executive’s availability to perform such duties or that could adversely affect,
or negatively reflect upon, the Company. 

e. Place of Performance. The duties to be performed by
the Executive hereunder shall be performed primarily at the offices of the
Company in Skillman, NJ, or at such other place as the Company may from time to
time reasonably designate. The Executive shall undertake such travel as may be
reasonably necessary to perform his duties hereunder and promote and sustain the
business interests of the Company. 

f. Code of Ethics; Insider Trading Policy. The Executive
shall familiarize himself and at times comply with the Company’s rules of
conduct as from time to time in effect, including without limitation, the
Primus Therapeutics, Inc. Code of Ethics and Insider Trading
Policy. 

2. Compensation.  

As compensation for the performance by the Executive of his
duties under this Agreement, the Company shall pay the Executive as follows:

a. Base Salary. Prior to the completion an initial
public offering of the Company’s common stock (the “Offering”), the
Company shall pay the Executive a base salary of One Dollar ($1.00) per year.
Promptly following the completion of an Offering, the Compensation Committee of
the Board of Directors of the Company shall determine a revised base salary for
the Executive (which shall be deemed effective as of the date of completion of
the Offering), which shall be commensurate with current market standards. The
Executive’s base salary shall thereafter be reviewed annually by the
Compensation Committee.

b. Bonus. Subject to the completion of a public
offering, and provided that the Company is operating profitably, the Board, upon
recommendation of the Compensation Commitee, may, in its sole discretion, grant
the Executive an annual bonus. Such bonus shall take into account the Board’s
evaluation of the Executive’s attainment of individual and corporate goals, and
the recommendations of the President & Chief Executive Officer of the
Company. 

c. Expenses. The Company shall reimburse the Executive
for all normal, usual and necessary expenses incurred by the Executive in
furtherance of the business and affairs of the Company, including reasonable
travel and entertainment, upon timely receipt by the Company of appropriate
vouchers or other proof of the Executive’s expenditures and otherwise in
accordance with any expense reimbursement policy as may from time to time be
adopted by the Company.

d. Other Benefits. The Executive shall be entitled to
participate in any corporate benefit or other plan (including, without
limitation, medical and dental insurance, medical reimbursement and hospital
plans, pension plans, employee stock purchase plans, profit sharing plans, bonus
plans, long term disability plans, life insurance and other so-called “fringe”
benefits) as the Company may make available to its senior executives from time
to time. 

e. Vacation. The Executive
shall be entitled to twenty (20) paid vacation days per annum, not more than ten
(10) of which shall be taken in succession, in addition
to public holidays observed by the Company. Commencing with the calendar year ending December 31, 2011, the Executive shall forfeit any annual vacation days not utilized with fifteen (15) months following the start of such calendar year.

 - 2 -

f. Withholding. The Company shall withhold all applicable federal, state and local taxes, social security charges and such other amounts as may be required by law from all amounts payable to the Executive under this Section 2. 

3. Confidential Information. 

a. Definition. For purposes of this Agreement, “Confidential Information” means all proprietary business information of any kind whatsoever, whether written, oral, in electronic format, and whether gathered by inspection or
observation, disclosed prior to or after the date of this Agreement, of or relating to the Company (or of or relating to any third party as to which the Company has any obligation of confidentiality or non-disclosure), including without limitation
the following: (i) business plans, projections and production schedules; (ii) financial statements and projections or forecasts of financial results; (iii) product specifications, formulae, know-how and processing instructions; (iv) computer
programs; (v) names and addresses of vendors, and raw material and logistics costs; (vi) customer or other mailing lists, purchasing history and other customer-related records; (vii) tax information; (viii) personnel data and training manuals; (ix)
corporate documents and contracts; (x) correspondence (including e-mail communications); and (xi) any copies, summaries or annotation of any of the foregoing; provided, however, that the term “Confidential Information” shall not
include any information: (A) that the Executive can document was lawfully in his possession prior to any disclosure thereof by the Company; (B) is obtained on a non-confidential basis from a source other than the Company, but only if such source has
a lawful right to disclose such Confidential Material; or (C) is or becomes in the public domain. 

b. Executive’s Obligations. The Executive recognizes and acknowledges that in the course of his duties he is likely to receive Confidential Information and that such Confidential Information represents a valuable asset of the Company.
The Executive therefore covenants and agrees, during and after the Term, to keep confidential any and all Confidential Information and not disclose or make accessible to any other person, or use for any purpose other than in connection with the
fulfillment of his duties under this Agreement, any Confidential Information The Executive agrees to return immediately to the Company all Confidential Information in his possession upon request and in any event immediately upon termination of
employment. 

c. Required Disclosure. In the event Executive is ordered by any court or governmental agency to disclose any Confidential Information, the Executive shall inform Primus as soon as is practical (unless prohibited by law from so doing) in
order that Primus may seek a protective order or other relief. Executive shall disclose only such of the Confidential Information as is legally required. 

d. Remedies. The Executive stipulates and agrees that money damages would not be an adequate remedy for any breach of this Section 3 and that the Company
shall be entitled to equitable relief, including an injunction and specific performance, in the event of any breach or threatened breach of this Section 3, in addition to any other remedies at law or in equity. 

 - 3 -

e. Survival. The provisions of this Section 3 shall survive any termination of this Agreement indefinitely. 

4. Termination. 

a. Notice. Either Party may terminate this Agreement upon thirty (30) days written notice to the other, such thirtieth (30th) day being herafter referred to as the “Termination Date”. 

b. Payment Upon Termination. Upon termination of this Agreement the Company shall pay or, as the case may be, reimburse to the Executive: (i) the Executive’s base salary, calculated through and including the Termination Date; (ii)
compensation for any unused vacation or other paid time off, calculated based upon the Executive’s base salary then in effect; and (iii) any business expenses incurred prior to the Termination Date and not previously reimbursed, provided that
the Executive shall submit claims for unreimbursed expenses not later than thirty (30) days following the Termination Date. 

5. Indemnification. 

The Company shall defend and indemnify the Executive in his capacity as Treasurer and Chief Financial Officer of the Company to the fullest extent permitted under to the Delaware General Corporation Law and in accordance with the Company’s
Bylaws, as from time to time in effect, and in accordance with any separate contractual indemnification arrangements between the Company and the Executive. The Company shall also establish and maintain in effect a policy for indemnifying its
officers and directors, including but not limited to the Executive, for all lawful actions taken in good faith pursuit of their duties for the Company, including but not limited to the obtaining of an appropriate level of Directors and Officers
Liability coverage and including such provisions in the Company’s by-laws or certificate of incorporation, as applicable and customary. The rights to indemnification shall survive any termination of this Agreement. 

6. Miscellaneous. 

a.  Governing Law. This Agreement shall be governed by, and construed and interpreted in accordance with, the laws of the State of Delaware, as applicable to contracts performed wholly within the state. 

b. Jurisdiction. Any dispute arising hereunder shall be subject to the non-exclusive jurisdiction of the courts of New Jersey and United States District Court for the District of New Jersey sitting in Mercer County. 

c.  Binding Effect. This Agreement shall be binding upon and inure to the benefit of the parties hereto, and their respective heirs, legal representatives, successors and assigns. 

 - 4 -

d. Assignment. The Executive may not assign any right, or delegate any obligation, arising under this Agreement. The Company may assign its rights and/or delegate its obligations hereunder in connection with any sale, transfer or other
disposition of all or substantially all of its business or assets. 

e. Amendment, Waiver. This Agreement may be not be amended, or any provision hereof or right hereunder waived, other than by a written instrument signed by both Parties or, in the case of waiver, by the Party charged. The failure of either
Party to insist upon the strict performance of any covenant or agreement to be performed by the other Party hereunder shall not be construed as a waiver of future compliance with that or any other covenant or agreement, and such covenant or
agreement shall remain in full force and effect. 

f.  Notice. All notices given hereunder shall be in writing and shall be delivered personally, by overnight courier service or registered or certified mail, delivery charges prepaid and return receipt requested, addressed to the recipient
Party at the address set forth on the first page of this Agreement (or such other address as the Party in question shall by prior written notice have designated), and shall be deemed given when actually received. 

g. Section Headings. The section headings contained herein are for reference purposes only and shall not in any way affect the meaning or interpretation of this Agreement. 

h. Execution in Counterparts. This Agreement may be executed in any number of counterparts, each of which shall constitute an original, but all of which together shall constitute one and the same instrument. 

IN WITNESS WHEREOF, the parties hereto have executed this Agreement, which shall be deemed effective as of the Effective Date set forth above. 

PRIMUS THERAPEUTICS, INC. 

By:     /s/ Dennis M. O’Donnell 

           
 Dennis M. O’Donnell 

           
 President & Chief Executive Officer 

MARK I. MASSAD 

By:      /s/ Mark I. Massad 

- 5 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00184-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00184-of-00352.parquet"}]]